{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:17:32Z","timestamp":1783160252771,"version":"3.54.6"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111010","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:01:33Z","timestamp":1757548893000},"page":"111010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenotyping and genotyping for the dihydropyrimidine dehydrogenase test in Italy: a precise diagnostic strategy to detect rare variants and improve drug administration"],"prefix":"10.1016","volume":"140","author":[{"given":"Maria Lucia","family":"Tommolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Zucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Frisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Dufrusine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Palmarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9768-751X","authenticated-orcid":false,"given":"Luca","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Stuppia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"Pieragostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.111010_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/geno.1998.5379","article-title":"Characterization of the human dihydropyrimidine dehydrogenase gene","volume":"51","author":"Wei","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.acr.2014.10.007","article-title":"Role of ABC transporters in fluoropyrimidine-based chemotherapy response","volume":"125","author":"Nies","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0015","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2147\/PGPM.S337147","article-title":"Ethnic diversity of DPD activity and the DPYD gene: review of the literature","volume":"14","author":"White","year":"2021","journal-title":"PGPM"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0020","unstructured":"Ontario Health (Quality) DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment. Ont Health Technol Assess Ser 2021, 21, 1\u2013186."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0025","unstructured":"Italian Association of Medical Oncology (AIOM). Recommendations for Molecular Genetic Testing to Assess Gene Variants Involved in the Metabolism of Chemotherapeutic Drugs. Milan: AIOM; 2019. Available from: Https:\/\/Www.Aiom.It\/Wp-Content\/Uploads\/2019\/10\/2019_Raccomandazioni-Analisi-Farmacogenetiche.Pdf."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101197","article-title":"\u2018The working group on the implementation of DPD-deficiency testing in Europe\u2019 implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe","volume":"8","author":"de With","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/chromsci\/bms085","article-title":"Validation of an ultra-high performance liquid chromatography tandem mass spectrometric method for quantifying uracil and 5,6-dihydrouracil in human plasma","volume":"50","author":"Coudor\u00e9","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fonc.2019.00139","article-title":"Rare dihydropyrimidine dehydrogenase variants and toxicity by floropyrimidines: a case report","volume":"9","author":"Palmirotta","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0055","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3390\/cancers14133207","article-title":"Testing for dihydropyrimidine dehydrogenase deficiency to individualize 5-fluorouracil therapy","volume":"14","author":"Diasio","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41416-020-0962-z","article-title":"A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency","volume":"123","author":"Pallet","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/jpm10030113","article-title":"A genotyping\/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: clinical cases and systematic review of the literature","volume":"10","author":"Conti","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/147323001003800413","article-title":"The value of dihydrouracil\/uracil plasma ratios in predicting 5-fluorouracil-related toxicity in colorectal cancer patients","volume":"38","author":"Kristensen","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cpt.210","article-title":"Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil\/uracil ratio","volume":"99","author":"Thomas","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2006.09.006","article-title":"5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency","volume":"249","author":"Boisdron-Celle","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bcp.12790","article-title":"Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-fu in patients with digestive cancer","volume":"81","author":"Launay","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.1999.17.4.1105","article-title":"Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage","volume":"17","author":"Gamelin","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/2212697X04666170817123425","article-title":"Upfront dpd deficiency detection to secure 5-fu administration: part 2- application to head-and-neck cancer patients","volume":"4","author":"Launay","year":"2017","journal-title":"Clin Cancer Drugs"},{"key":"10.1016\/j.clinbiochem.2025.111010_b0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00384-015-2191-0","article-title":"Lethal 5-fluorouracil toxicity in a colorectal patient with severe dihydropyrimidine dehydrogenase (DPD) deficiency","volume":"31","author":"Dhelens","year":"2016","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03257473","article-title":"Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a bayesian limited sampling strategy","volume":"51","author":"van Kuilenburg","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.15386\/mpr-1564","article-title":"A review on the importance of genotyping and phenotyping in fluoropyrimidine treatment","volume":"93","author":"Deac","year":"2020","journal-title":"Med. Pharm. Rep."},{"key":"10.1016\/j.clinbiochem.2025.111010_b0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmoldx.2024.05.015","volume":"26","author":"Pratt","year":"2024","journal-title":"J. Mol. Diagn."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:43:46Z","timestamp":1783158226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"alternative-id":["S0009912025001390"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotyping and genotyping for the dihydropyrimidine dehydrogenase test in Italy: a precise diagnostic strategy to detect rare variants and improve drug administration","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111010"}}